Mercury

Mercury is a purpose-built early-stage venture capital platform dedicated to supporting transformative software startups in communities across America, particularly in Middle America. The company identifies and partners with exceptional founders, offering both guidance to new entrepreneurs and resources to experienced innovators. With a focus on operationally-driven investment strategies, Mercury has generated over $9 billion in value, facilitating rapid and sustainable growth for its portfolio companies. Through its comprehensive growth partner network, Mercury aims to leverage local assets and talent, fostering entrepreneurship and innovation within the regions it serves.

Patrick Okorafor

Director of Finance

Past deals in Houston, TX

Topl

Series A in 2022
Topl is a blockchain-based technology company that enables organizations to monetize ethical and sustainable practices by recording verified impact on a transparent, auditable ledger. It provides a decentralized protocol and accompanying services designed to build an impact technology economy, allowing enterprises to prove and monetize their positive impact as an asset across industries and borders. The Topl platform offers blockchain infrastructure, a blockchain for impact verification, and hosted tooling that simplifies interaction with the network, including supply chain certification and related services. By combining cross-border projects with verifiable impact data, Topl helps brands unlock value from social and environmental programs while providing a scalable solution for impact monetization.

Molecule Software

Series A in 2021
Molecule Software develops cloud-based energy trading and risk management software for commodity traders, risk managers, and operations teams. The platform accepts trade and position data from exchanges and spreadsheets, integrates market data, and computes position, profit and loss, and value-at-risk in real time, reducing the need for lengthy implementations. It supports sectors including electricity, natural gas, NGLs, and crude. The company is based in Houston, Texas, and was founded in 2012.

Topl

Seed Round in 2020
Topl is a blockchain-based technology company that enables organizations to monetize ethical and sustainable practices by recording verified impact on a transparent, auditable ledger. It provides a decentralized protocol and accompanying services designed to build an impact technology economy, allowing enterprises to prove and monetize their positive impact as an asset across industries and borders. The Topl platform offers blockchain infrastructure, a blockchain for impact verification, and hosted tooling that simplifies interaction with the network, including supply chain certification and related services. By combining cross-border projects with verifiable impact data, Topl helps brands unlock value from social and environmental programs while providing a scalable solution for impact monetization.

Molecule Software

Seed Round in 2014
Molecule Software develops cloud-based energy trading and risk management software for commodity traders, risk managers, and operations teams. The platform accepts trade and position data from exchanges and spreadsheets, integrates market data, and computes position, profit and loss, and value-at-risk in real time, reducing the need for lengthy implementations. It supports sectors including electricity, natural gas, NGLs, and crude. The company is based in Houston, Texas, and was founded in 2012.

Apsara Therapeutics

Debt Financing in 2014
Apsara Therapeutics is a biotechnology company based in Houston, Texas, focused on developing antibody therapies for the treatment of neuromyelitis optica (NMO), a demyelinating disorder that affects the spinal cord and optic nerve. The company’s innovative therapies aim to block the formation of lesions associated with NMO and halt the inflammatory processes that can lead to demyelination and neuronal cell death. By employing a novel approach to treat antibody-mediated immune disorders, Apsara Therapeutics seeks to provide effective solutions for patients suffering from this debilitating condition.

Apsara Therapeutics

Debt Financing in 2014
Apsara Therapeutics is a biotechnology company based in Houston, Texas, focused on developing antibody therapies for the treatment of neuromyelitis optica (NMO), a demyelinating disorder that affects the spinal cord and optic nerve. The company’s innovative therapies aim to block the formation of lesions associated with NMO and halt the inflammatory processes that can lead to demyelination and neuronal cell death. By employing a novel approach to treat antibody-mediated immune disorders, Apsara Therapeutics seeks to provide effective solutions for patients suffering from this debilitating condition.

Molecule Software

Seed Round in 2013
Molecule Software develops cloud-based energy trading and risk management software for commodity traders, risk managers, and operations teams. The platform accepts trade and position data from exchanges and spreadsheets, integrates market data, and computes position, profit and loss, and value-at-risk in real time, reducing the need for lengthy implementations. It supports sectors including electricity, natural gas, NGLs, and crude. The company is based in Houston, Texas, and was founded in 2012.

Molecule Software

Seed Round in 2012
Molecule Software develops cloud-based energy trading and risk management software for commodity traders, risk managers, and operations teams. The platform accepts trade and position data from exchanges and spreadsheets, integrates market data, and computes position, profit and loss, and value-at-risk in real time, reducing the need for lengthy implementations. It supports sectors including electricity, natural gas, NGLs, and crude. The company is based in Houston, Texas, and was founded in 2012.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.